Condition
Breast Implant Revision
Total Trials
6
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
3 terminated out of 6 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
3 of 0 completed with results
Key Signals
3 with results0
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Terminated3
Not Yet Recruiting1
Active Not Recruiting1
Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07367698Not ApplicableRecruitingPrimary
Scaffold-guided Breast Implant Revision Surgery
NCT07383012Not Yet RecruitingPrimary
LTFU of PCL Breast Scaffolds Used in 2021-BRV-004
NCT05437757Not ApplicableActive Not RecruitingPrimary
Scaffold-guided Breast Surgery
NCT01785069Not ApplicableTerminated
Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants
NCT01870869Not ApplicableTerminated
NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study
NCT01853605Not ApplicableTerminated
NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study
Showing all 6 trials